STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating Activities:
Net income/(loss)	$ (9,130,274)	$ (17,069,896)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	74,142	95,238
Share-based compensation	1,009,792	2,243,445
Stock issued for warrant settlement	743,459
Stock issued for services	38,500	92,750
Gain on lease modification		(84,678)
Loss on disposal of assets		77,210
Amortization of debt discount	103,530	1,809,566
Operating lease asset amortization	484,300	667,526
Loss on equity method investment	2,666	232
Patent write off	18,991	26,419
Inventory write off and reserve expense	(34,658)	114,301
Impairment loss	524,481	3,283,715
Gain on settlement of liabilities, net	(165,548)
Gain on Swiss liabilities (Note 5)	(541,021)
Changes in operating assets and liabilities:
Accounts receivable		1,769
Inventories	29,051	(124,760)
Prepaid expenses and other current assets	(49,795)	192,273
Accounts payable	(129,800)	(15,920)
Related party payable	1,538	(62,933)
Operating lease liabilities	(491,440)	(649,991)
Accrued interest	28,176	69,085
Accrued expenses	(939,659)	(202,230)
Net cash (used in) operating activities	(8,423,569)	(9,536,879)
Investing Activities:
Purchase of property, plant and equipment	(421)	(3,857,783)
Patent activity costs		(19,583)
Net cash provided by (used in) investing activities	(421)	(3,877,366)
Financing Activities:
Proceeds from issuance of stock and warrants	15,145,123	10,289,228
Proceeds from bridge loans	1,153,750
Repayment of bridge loans	(1,218,465)
Payment of Series 1B Preferred Stock		(900,000)
Financing issuance cost	(1,367,744)	(1,088,796)
Warrant repurchase	(3,600,000)
Payment of convertible notes, cash payable, and other payable	(381,664)	(6,237,712)
Net cash provided by (used in) financing activities	10,546,000	2,962,720
Effect of foreign exchange rate on cash		17,240
Net change in cash and cash equivalents	2,122,010	(10,434,285)
Cash and cash equivalents at beginning of period	1,048,733	11,483,018
Cash and cash equivalents at end of period	3,170,743	1,048,733
Non-Cash Transactions:
Conversions of preferred stock, convertible notes, and conversions payable to equity	1,256,692	3,082,400
Exercise of prefunded warrants	22	247
Purchase and return of equipment purchased on credit		(202,558)
Down round deemed dividend		17,980,678
Series 1B Preferred Stock
Financing Activities:
Proceeds from issuance of Preferred Stock		$ 900,000
Series I C Preferred Stock
Financing Activities:
Proceeds from issuance of Preferred Stock	$ 815,000